Select the type of procedure
21232821
1
Enquiry period
with
31.05.2024 14:11
to 12.06.2024 16:41
to 12.06.2024 16:41
2
Bidding period
with
12.06.2024 16:41
to 20.06.2024 19:41
to 20.06.2024 19:41
3
Auction
will not be used
4
Evaluation
5
Contract
Status
Evaluation
Estimated value without VAT
2 198 859,30 MDL
Period of clarifications:
31 May 2024, 14:11 - 12 Jun 2024, 16:41
Submission of proposals:
12 Jun 2024, 16:41 - 20 Jun 2024, 19:41
Supplier technical support:
(+373) 79999801
This procedure is carried out without auction. Your offer is final and must contain the entire list of required documents.
Subscribe impossible
during the period Evaluation
Achiziționarea medicamentelor necesare instituțiilor medico-sanitare publice (IMSP) și instituțiilor bugetare care prestează servicii medicale și sociale pentru anul 2024 (suplimentar nr. 9)
Information about customer
Fiscal code/IDNO
Address
MD-2009, MOLDOVA, mun.Chişinău, locality, MD-2009, Republica Moldova, Chişinău str. Cosmescu 3
Web site
---
The contact person
Purchase data
Date created
31 May 2024, 14:00
Date modified
7 Jun 2024, 9:10
Achizitii.md ID
21232821
MTender ID
CPV
33600000-6 - Produse farmaceutice
Type of procedure
Open tender
Award criteria
The lowest price
Funding sources
List of lots
Lot nr. 2 - Acidum acetylsalicylicum 325 mg
Budget: 206.94 MDL
Purchase has not taken place
Lot nr. 4 - Actovegin 200 mg (sau echivalentul) 40mg/ml 5 ml
Budget: 17623.13 MDL
Purchase has not taken place
Lot nr. 10 - Carbamazepinum 150 mg sau 200mg
Budget: 199248.19 MDL
Purchase has not taken place
Lot nr. 11 - Carbamazepinum 300 mg sau 400mg
Budget: 554415.88 MDL
Purchase has not taken place
Lot nr. 14 - Cerebrolysinum 215.2 mg/ml 5 ml
Budget: 19338.81 MDL
Purchase has not taken place
Lot nr. 16 - Clarithromycinum 500 mg, comprimate
Budget: 950.46 MDL
Purchase has not taken place
Lot nr. 17 - Desmopressinum 5-10 mcg/doza 5 ml
Budget: 174.0 MDL
Purchase has not taken place
Lot nr. 22 - Ethylmethylhydroxypyridine succinate50 mg/ml 2 ml
Budget: 1859.01 MDL
Purchase has not taken place
Lot nr. 25 - Fondaparinuxum sodium 2.5 mg/0.5 ml
Budget: 21424.05 MDL
Purchase has not taken place
Lot nr. 26 - Fondaparinuxum sodium 7.5 mg/0.6 ml
Budget: 23214.79 MDL
Purchase has not taken place
Lot nr. 32 - Insulinum aspartum biphasic 100 UI/ml 3 ml
Budget: 1822.65 MDL
Purchase has not taken place
Lot nr. 33 - Insulinum humanum (act.interm.) 100 UI/ml 10 ml
Budget: 407.85 MDL
Purchase has not taken place
Lot nr. 34 - Insulinum humanum (act.rap) 100UI/ml 10 ml
Budget: 8150.48 MDL
Purchase has not taken place
Lot nr. 36 - Iopromidum 768,86 mg/ml 50 ml
Budget: 279920.76 MDL
Purchase has not taken place
Lot nr. 43 - Levosimendanum 2.5 mg/ml 5 ml
Budget: 33333.33 MDL
Purchase has not taken place
Lot nr. 46 - Metforminum/Metformini hydrochloridum 1000 mg
Budget: 2538.72 MDL
Purchase has not taken place
Lot nr. 53 - Natrii chloridum/Sodium chloridum 0.9% 500 ml
Budget: 115.27 MDL
Purchase has not taken place
Lot nr. 54 - Natrii chloridum+Kalii chloridum+Calcii chloridum (analog Ringer) 0,86 g+0,03 g+0,033 g/100 ml 400 ml-500 ml
Budget: 236.96 MDL
Purchase has not taken place
Lot nr. 57 - Nifuroxazidum 200-220 mg/5 ml
Budget: 461.88 MDL
Purchase has not taken place
Lot nr. 60 - Phenobarbitalum 200 mg/ml 1 ml
Budget: 2830.83 MDL
Purchase has not taken place
Lot nr. 61 - Pipecuronii bromidum 4 mg+2 ml
Budget: 4576.25 MDL
Purchase has not taken place
Lot nr. 62 - Povidoni iodidum (solutie nestandardizata de Povidon-iod) 100 mg/ml 100-120 ml
Budget: 13022.7 MDL
Purchase has not taken place
Purchase has not taken place
Lot nr. 68 - Spiritus aethylicus 70% 100 ml
Budget: 2100.0 MDL
Purchase has not taken place
Lot nr. 69 - Spiritus aethylicus 70% 1000 ml
Budget: 826.19 MDL
Purchase has not taken place
Lot nr. 70 - Sulfamethoxazolum+Trimethoprimum 400 mg+80 mg
Budget: 944.56 MDL
Purchase has not taken place
Lot nr. 74 - Tincturae Valerianae + Leonurus +Crataegus 50 ml
Budget: 442.0 MDL
Purchase has not taken place
Lot nr. 75 - Tirofibanum 0,25 mg/ml 50 ml
Budget: 112436.3 MDL
Purchase has not taken place
Lot nr. 79 - Urolesan (sau echivalentul din punct de vedere al compozitiei calitative sicantitative) 25 ml
Budget: 443.0 MDL
Purchase has not taken place
Documents of the procurement procedure
Documentatia standard_31.05.2024.signed
Bidding Documents
Documentatia standard_31.05.2024
31.05.24 14:11
Model de contract_LP suplimentar nr. 9_data de 31.05.2024
Bidding Documents
Model de contract_LP suplimentar nr. 9_data de 31.05.2024
31.05.24 14:11
Declaratie beneficiari efectivi_Model
Bidding Documents
Declaratie beneficiari efectivi_Model
31.05.24 14:11
Declaratie privind valabilitatea ofertei_Model
Bidding Documents
Declaratie privind valabilitatea ofertei_Model
31.05.24 14:11
Lista de distributie_Med pu 2024 (suplimentar nr. 9)
Bidding Documents
Lista de distributie_Med pu 2024 (suplimentar nr. 9)
31.05.24 14:11
Scrisoare de garantie bancara_Model
Technical Specifications
Scrisoare de garantie bancara_Model
31.05.24 14:11
Anexa_Anunt de participare_10.06.2024.signed.pdf
Documents history
-
Anexa_Anunt de participare_10.06.2024.signed.pdf
ID: 97582913-b190-46c3-a03d-20a0f26a4b9c
Bidding Documents
-
Anunt de participare_31.05.2024.signed
ID: 97582913-b190-46c3-a03d-20a0f26a4b9c
Bidding Documents
Bidding Documents
Anexa_Anunt de participare_10.06.2024.signed.pdf
11.06.24 09:51
Date:
7 Jun 2024, 09:10
Question's name:
Poziția 48 - Milrinonum 1 mg/ml 10 ml
Question:
Cu referire la poziția 48 - Milrinonum 1 mg/ml 10 ml, solicităm să modificați caietul de sarcini privind statutul acestui preparat conform Nomenclatorului de Stat al Medicamentelor - medicamente autorizate (la momentul deschiderii ofertelor), ținând cont de faptul că acest produs a fost autorizat în Republica Moldova (referință - ordinul AMDM nr. Nr. Rg04-000112 din 03.05.2024)
Answer (10 Jun 2024, 16:41):
Bună ziua!
Documentația de atribuire a fost modificată. În vederea publicării anunțului de participare rectificat, a fost înaintată solicitare de acordare a suportului din partea Centrului de Tehnologii Informaționale în Finanțe.
Vă mulțumim pentru clarificare!
Only authorized platform users may ask questions during the clarification period.
Document successfully signed
OK